Umbilical cord blood banking raises several issues in legal and ethical terms, from the determination of ownership
of biological material to the respect of the right of self determination–namely, the right to give an informed
consent–of the individuals involved (newborn, parents), to the commercialization of cord blood banks and to the
related autologous use of donated placental blood.
Recently these issues have been considered by the European Group on Ethics in Science and New Technologies
to the European Commission (EGE) in the Opinion on “Ethical aspects of umbilical cord blood banking” (Opinion
No. 19 of 16 March 2004). They have also been part of a wide and intense international debate.
This paper aims at examining these themes–ownership, informed consent, and commercialization of cord blood
banking–with particular regard to the EGE Opinion on the ethical aspects of umbilical cord blood banking. Such
opinion focuses on private cord blood banks for autologous use and underlines the legitimacy conditions for these
banks’ activities.
